The physical compatibility of ternary admixtures was assessed using visual inspection and pH determination of ternary admixtures immediately after preparation (at 0 time) and after 24 hrs. The chemical stability was assessed using high performance thin layer chromatoghraphy (HPTLC). The method is based on HPTLC separation of the three drugs followed by densitometric measurements of their spots at 254 nm using Camag TLC Scanner 3. The mobile phase comprised ethyl acetate : n-propanol : water : glecial acetic acid (60:24:9:3, v/v/v/v
INTRODUCTION
Physicochemical incompatibilities between injected drugs frequently occur in hospitals. Physicochemical incompatibilities of intravenous solutions are major concerns in medication errors 1&2 . Drug incompatibilities are frequent and may occur between active ingredients, excipients, and even tubing 3 . They emerge as color change, gas formation, turbidity and precipitation or may lead to invisible chemical reactions such as pH changes or complex reactions which can result in loss of active compounds or reduced bioavailability of the active ingredient 4 . Compatibility is not certain for drug combinations in which the compatibility is unknown or ambiguous for up to 45% of coinfusions in an intensive care units (I.C.Us.) 5 .
Unfortunately there is only data describing the physical or chemical compatibility of approximately half of the possible 2-medication combinations (and virtually no data for 3 or more medication combinations) commonly used in (I.C.Us.) 6 . Intravenous drug administration in neonatal intensive care units (N.I.C.Us.) and pediatric intensive care units (P.I.C.Us.) is critical because of poor venous access, polymedication, fluid restriction and low infusion rate. Risk is further increased by inadequate information on the physicochemical compatibility of drugs 7 . Chemical compatibility requires analytical techniques such as high performance liquid chromatography to confirm at least 90% availability of both drugs in combination over the duration of mixing 8 . Midazolam, dobutamine and dopamine are commonly used in neonatal intensive care units. Midazolam is a short acting benzodiazepine used in NICU as sedative drug to reduce stress and avoid complications during procedures such as mechanical ventilation 9 .
Midazolam is safe and effective for the treatment of uncontrollable neonatal seizures which could not be controlled by diazepam, phenytoin or phenobarbital 10 . Adverse effects of midazolam included hypotension that was successfully controlled with intropic agents (dopamine and/or dobutamine) 10 . Also, hypotension is a common medical problem in neonatal intensive care units, especially among the most premature infants
11&12
. The requires administration of dopamine and/or dobutamine as inotropic drugs. Some neonatal medical cases, need to use ternary admixture of midazolam, dobutamine and dopamine. The use of ternary admixture is advantageous as it reduce the volume of fluid that can be administered after separate administration of each drug. This is extremely important in neonates. The objective of this study was to evaluate physical compatibility and chemical stability of maximum concentrations of midazolam, dobutamine and dopamine that can be used in clinical practice in N.I.C.U. when admixed together with 5% glucose solution or 0.9% NaCl solution.
MATERIALS AND METHODS

Reagents and materials
Dormicum ampoules (Midazolam hydrochloride for injection 5 mg/ml, F.Hoffmann-La Roche Ltd., France). Dobutamine ampoules (Dobutamine hydrochloride for injection 250 mg/5 ml, EUP, for pharmaceutical and chemical industry, Egypt). Dopamine ampoules (Dopamine hydrochloride for injection 200 mg/5 ml, EUP, for pharmaceutical and chemical industry, Egypt). 5% glucose intravenous solution and 0.9% sodium chloride intravenous solution. Thin layer chromatoghraphy aluminium sheets (precoated with silica gel 60 F 254 plates 20x20 with 0.250 mm layer thickness, E. Merck, Germany). Ethyl acetate, n-propanol and acetic acid glacial (All chemicals used were of pharmaceutical grade).
Instruments
Digital pH meter (Jenway Ltd., Feslted, Dunmow, U.K.) and Camag TLC-Scanner III (Switzerland, comprising of Camag Linomat 5 applicator, Camag TLC Scanner 3, Camag WinCATS software, Hamilton syringe (100 μl), Camag Reprostar 3, Camag UV Cabinet).
Preparation of admixtures
Midazolam admixture was prepared by transferring 1.44 ml solution from dormicum ampoules to volumetric flask 50 ml. The volume was completed to 50 ml with 5% glucose or 0.9% sodium chloride solution. The final concentration of midazolam was 0.144 mg/ml. Dobutamine admixture was prepared by transferring 5.76 ml solution from dobutamine ampoules to volumetric flask 50 ml. The volume was completed to 50 ml with 5% glucose or 0.9% sodium chloride solution. The final concentration of dobutamine was 5.76 mg/ml. Dopamine admixture was prepared by transferring 3.6 ml solution from dopamine ampoule to volumetric flask 50 ml. The volume was completed to 50 ml with 5% glucose or 0.9% sodium chloride solution. The final concentration of dopamine was 2.88 mg/ml.
Ternary admixture of midazolam, dobutamine and dopamine was prepared by transferring 1.44 ml of midazolam ampoules (equivalent to 7.2 mg) to 50 ml volumetric flask. The flask was shaken gently after adding small amount of 5% glucose or 0.9% sodium chloride solution. To the same flask, 5.76 ml of dobutamine ampoule (equivalent to 288 mg) was added and mixed carefully by gentle shaking. At the end, 3.6 ml of dopamine ampoule (equivalent to 144 mg) was added and mixed carefully. The volume was adjusted with infusion fluids. The final concentration of midazolam was 0.144 mg/ml, dobutamine was 5.76 mg/ml and dopamine was 2.88 mg/ml.
The temperature of preparation and storage were at room temperature.
Investigation of physical compatibility of admixtures
The physical compatibility of admixture was assessed using visual inspection and pH determination of admixture immediately after preparation (at 0 time) and after 24 hrs. Visual inspection was conducted to detect precipitation (against a black background), gas formation, turbidity or color change (against a white background and compare with color of water) immediately after preparation of admixtures and then after 24 hrs.
Investigation of chemical stability of admixtures using Camag TLC-Scanner III
A large number of publications have appeared in the last decade on the use of HPTLC (high performance thin layer chromatography) for stability studies [13] [14] [15] [16] [17] . Chemical stability of admixture was assessed by comparing between R f , peak area and absorbance of each drug immediately after preparation of ternary admixture and after 12 and 24 hrs in 5% glucose or 0.9% sodium chloride solution.
Chromatographic conditions
Three microlitres of solutions of drugs was applied to plates (20x10 cm) by means of a Linomat V automatic spotter, equipped with a 100 μL syringe and operated with settings of band length, 4 mm; distance between bands, 10 mm; distance from the plate edge, 10 mm; and distance from the bottom of the plate, 10 mm at room temperature (25±2°C). The plate was developed in a twin trough chamber previously saturated for 60 min with mobile phase to ensure good reproducibility for peak shapes and areas of drugs by using ethyl acetate : npropanol : water : glacial acetic acid, 60:24:9:3, (v/v/v/v) as mobile phase to 8.0 cm. The developed TLC plates were dried in a current of air. The slit dimension was kept at 3.0 mm x 0.45 mm and the scanning speed was 10 mm/s. Densitometric scanning was performed using a Camag TLC scanner III in the absorbance mode at 254 nm and operated by CATS software.
RESULTS AND DISCUSSION
Physical compatibility of ternary admixture
There was no precipitation, gas evaluation, change in colour or change in pH of ternary admixture at zero time and after 24 hrs in 5% glucose solution or 0.9% sodium chloride solution. The pH values are presented in table 1.
Chemical stability of admixtures by Camag TLC-Scanner III 5% glucose solution
The mobile phase consisting of ethyl acetate : n-propanol : water : glecial acetic acid 60:24:9:3 (v/v/v/v) gave good resolution for midazolam, dobutamine and dopamine.
By densitometric evaluation "Chromatogram evaluation": There was no indication of degradation and no unknown peaks were observed on TLC chromatogram at 0, 12 and after 24 hrs. Figure 1 show TLC chromatograms of maximum concentrations of midazolam alone in 5% glucose solution at 0, 12 and after 24 hrs. There was no indication of degradation and no unknown peaks were observed. Figure 2 show TLC chromatograms of maximum concentrations of dobutamine alone in 5% glucose solution at 0, 12 and after 24 hrs. There was no indication of degradation and no unknown peaks were observed. There was no indication of degradation and no unknown peaks were observed. Figure 4 show TLC chromatograms of maximum concentrations of midazolam, dobutamine and dopamine in ternary admixture of 5% glucose solution at 0, 12 and after 24 hrs. There was no indication of degradation and no unknown peaks were observed.
Figures 5-7 display absorption spectra of maximum concentrations of midazolam, dobutamine and dopamine in ternary admixture of 5% glucose solution at 0, 12 and 24 hrs. It appears that the absorption spectra of midazolam, dobutamine and dopamine didn't change during 24 hrs with the same wavelength at λ max = 231 nm, 280 nm and 281 nm, respectively. No change in the spectra was detected over the study period.
0.9% sodium chloride solution
The mobile phase consisting of ethyl acetate : n-propanol : water : glecial acetic acid 60:24:9:3 (v/v/v/v) gave good resolution for midazolam, dobutamine and dopamine. By densitometric evaluation "Chromatogram evaluation": There was no indication of degradation and no unknown peaks were observed on TLC chromatogram at 0, 12 and after 24 hrs. Table 5 presents R f values and peak areas of maximum concentration of midazolam alone and in ternary admixture of 0.9% sodium chloride solution during 24 hrs. It appears that the R f values of midazolam at 0.64±0.01 didn't change during 24 hrs. Peak areas of midazolam in ternary admixture of 0.9% sodium chloride solution were within the range during 24 hrs. This is consistent with the previously reported result 19 revealing that midazolam is stable in 0.9% sodium chloride solution for 24 hrs. Table 6 presents R f values and peak areas of maximum concentration of dobutamine alone and in ternary admixture of 0.9% sodium chloride solution during 24 hrs. It appears that the R f values of dobutamine at 0.81±0.01 didn't change during 24 hrs. Peak areas of dobutamine in ternary admixture of 0.9% sodium chloride solution were within the range during 24 hrs. This is consistent with the previously reported results
20&21
that dobutamine is stable in 0.9% sodium chloride solution for 24 hrs. Table 7 presents R f values and peak areas of maximum concentration of dopamine alone and in ternary admixture of 0.9% sodium chloride solution during 24 hrs. It appears that the R f values of dopamine at 0.43±0.01 didn't change during 24 hrs. Peak areas of dopamine in ternary admixture of 0.9% sodium chloride solution were within the range during 24 hrs. The results are in agreement with previously results 21&23 that dopamine is stable in 0.9% sodium chloride solution for 24 hrs. Figure 8 show densitograms of maximum concentrations of midazolam alone in 0.9% sodium chloride solution at 0, 12 and after 24 hrs. There was no indication of degradation and no unknown peak can be observed. Figure 9 show densitograms of maximum concentrations of dobutamine in 0.9% sodium chloride solution at 0, 12 and after 24 hrs. There was no indication of degradation and no unknown peak can be observed. Figure 10 show densitograms of maximum concentrations of dopamine in 0.9% sodium chloride solution at 0, 12 and after 24 hrs. There was no indication of degradation and no unknown peak can be observed. Figure 11 show densitograms of maximum concentrations of midazolam, dobutamine and dopamine in ternary admixture of 0.9% sodium chloride solution at 0, 12 and after 24 hrs. There was no indication of degradation and no unknown peak can be observed.
Figures 12-14 display absorption spectra of maximum concentrations of midazolam, dobutamine and dopamine in ternary admixture of 0.9% sodium chloride solution at 0, 12 and 24 hrs. It appears that the absorption spectra of midazolam, dobutamine and dopamine didn't change during 24 hrs with the same wavelengths at 231 nm, 280 nm and 281 nm respectively. No significant change in the spectra can be detected during the study period. 
